Capabilities
Lipid Nanoparticles for Nucleic Acid Delivery
Polymeric Nanoparticles for Targeted Delivery
Polymeric Microspheres for Sustained Release Delivery
Services
Formulation Feasibility & Optimization
Process Development & Scale-up
Pre-clinical Batch Manufacturing
cGMP Manufacturing
Supporting Analytical Services
Solutions
Therapeutic Modalities
Drug Payloads
Drug Carriers
Resources
About
News
Events
Careers
Contact Us
Home
Resources
Partnership Opportunities in Drug Delivery (PODD) 2023 Pre-Conference Issue: An Interview with Jarlath Keating, CEO of Phosphorex
Partnership Opportunities in Drug Delivery (PODD) 2023 Pre-Conference Issue: An Interview with Jarlath Keating, CEO of Phosphorex
October 12, 2023
Jarlath Keating, CEO of Phosphorex, discusses strategies and approaches to optimize development and manufacturing of novel therapeutics.. .
CLICK HERE FOR ARTICLE.
Phosphorex can be found on pages 5-6.
Events
Login
Login
Password
Register
Username*
Password*
First Name*
Last Name*
Email*
File Name
Select File
Image (88x80)
Previous Post
Complimentary Webinar: The Right Microfluidic Mixing Platform Plays a Crucial Role in Advancing LNP Clinical Development
October 9, 2023